Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|November 11, 2022
Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian CancerMikhail S Chesnokov, Anil Yadav, Ilana ChefetzCell Death Discovery|October 14, 2022
Drug toxicity assessment: cell proliferation versus cell deathElena V Sazonova, Mikhail S Chesnokov, Boris Zhivotovsky, et al.Journal of Biomedical Science|March 21, 2024
A matter of new life and cell death: programmed cell death in the mammalian ovaryMikhail S Chesnokov, Aygun R Mamedova, Boris Zhivotovsky, et al.Frontiers in Oncology|August 12, 2021
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AMLMikhail S Chesnokov, Soheila Borhani, Marianna Halasi, et al.Peerj|March 22, 2017
Effect of method of deduplication on estimation of differential gene expression using RNA-seqAnna V Klepikova, Artem S Kasianov, Mikhail S Chesnokov, et al.Cell Death & Disease|July 15, 2021
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cellsMikhail S Chesnokov, Marianna Halasi, Soheila Borhani, et al.Cancers|April 3, 2021
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian CarcinomaMikhail S Chesnokov, Imran Khan, Yeonjung Park, et al.Peerj|June 12, 2018
Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinomaMikhail S Chesnokov, Polina A Khesina, Darya A Shavochkina, et al.Pageof 1